BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37670477)

  • 1. Transcription factor ETV4 promotes the development of hepatocellular carcinoma by driving hepatic TNF-α signaling.
    Qi D; Lu M; Xu P; Yao X; Chen Y; Gan L; Li Y; Cui Y; Tong X; Liu S; Zhao J; Liu N; Ye X
    Cancer Commun (Lond); 2023 Dec; 43(12):1354-1372. PubMed ID: 37670477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PBK overexpression promotes metastasis of hepatocellular carcinoma via activating ETV4-uPAR signaling pathway.
    Yang QX; Zhong S; He L; Jia XJ; Tang H; Cheng ST; Ren JH; Yu HB; Zhou L; Zhou HZ; Ren F; Hu ZW; Gong R; Huang AL; Chen J
    Cancer Lett; 2019 Jun; 452():90-102. PubMed ID: 30914208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation.
    Wu Q; Chen JX; Chen Y; Cai LL; Wang XZ; Guo WH; Zheng JF
    Cell Death Dis; 2018 Feb; 9(2):232. PubMed ID: 29445190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HBx increases chromatin accessibility and ETV4 expression to regulate dishevelled-2 and promote HCC progression.
    Zheng C; Liu M; Ge Y; Qian Y; Fan H
    Cell Death Dis; 2022 Feb; 13(2):116. PubMed ID: 35121725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ETV4 facilitates angiogenesis in hepatocellular carcinoma by upregulating MMP14 expression.
    Su H; Shu S; Tang W; Zheng C; Zhao L; Fan H
    Biochem Biophys Res Commun; 2023 Dec; 684():149137. PubMed ID: 37897911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FGF19/FGFR4-mediated elevation of ETV4 facilitates hepatocellular carcinoma metastasis by upregulating PD-L1 and CCL2.
    Xie M; Lin Z; Ji X; Luo X; Zhang Z; Sun M; Chen X; Zhang B; Liang H; Liu D; Feng Y; Wang Y; Li Y; Liu B; Huang W; Xia L
    J Hepatol; 2023 Jul; 79(1):109-125. PubMed ID: 36907560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HERC2 promotes inflammation-driven cancer stemness and immune evasion in hepatocellular carcinoma by activating STAT3 pathway.
    Liu Y; Xu Q; Deng F; Zheng Z; Luo J; Wang P; Zhou J; Lu X; Zhang L; Chen Z; Zhang Q; Chen Q; Zuo D
    J Exp Clin Cancer Res; 2023 Feb; 42(1):38. PubMed ID: 36721234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNF-α/NF-κB signaling epigenetically represses PSD4 transcription to promote alcohol-related hepatocellular carcinoma progression.
    Shi J; Song S; Li S; Zhang K; Lan Y; Li Y
    Cancer Med; 2021 May; 10(10):3346-3357. PubMed ID: 33932127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ETV4 mediates the Wnt/β-catenin pathway through transcriptional activation of ANXA2 to promote hepatitis B virus-associated liver hepatocellular carcinoma progression.
    Sun T; Zhang J
    J Biochem; 2021 Dec; 170(5):663-673. PubMed ID: 34347084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor-α promotes hepatocellular carcinogenesis through the activation of hepatic progenitor cells.
    Jing Y; Sun K; Liu W; Sheng D; Zhao S; Gao L; Wei L
    Cancer Lett; 2018 Oct; 434():22-32. PubMed ID: 29981431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Essential role of suppressor of cytokine signaling 1 (SOCS1) in hepatocytes and macrophages in the regulation of liver fibrosis.
    Mafanda EK; Kandhi R; Bobbala D; Khan MGM; Nandi M; Menendez A; Ramanathan S; Ilangumaran S
    Cytokine; 2019 Dec; 124():154501. PubMed ID: 30097285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-8 Induces Expression of FOXC1 to Promote Transactivation of CXCR1 and CCL2 in Hepatocellular Carcinoma Cell Lines and Formation of Metastases in Mice.
    Huang W; Chen Z; Zhang L; Tian D; Wang D; Fan D; Wu K; Xia L
    Gastroenterology; 2015 Oct; 149(4):1053-67.e14. PubMed ID: 26065367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesencephalic Astrocyte-Derived Neurotrophic Factor Inhibits Liver Cancer Through Small Ubiquitin-Related Modifier (SUMO)ylation-Related Suppression of NF-κB/Snail Signaling Pathway and Epithelial-Mesenchymal Transition.
    Liu J; Wu Z; Han D; Wei C; Liang Y; Jiang T; Chen L; Sha M; Cao Y; Huang F; Geng X; Yu J; Shen Y; Wang H; Feng L; Wang D; Fang S; Wang S; Shen Y
    Hepatology; 2020 Apr; 71(4):1262-1278. PubMed ID: 31469428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncostatin M promotes hepatic progenitor cell activation and hepatocarcinogenesis via macrophage-derived tumor necrosis factor-α.
    Yang X; Shao C; Duan L; Hou X; Huang Y; Gao L; Zong C; Liu W; Jiang J; Ye F; Shi J; Zhao Q; Wu D; Wei L
    Cancer Lett; 2021 Oct; 517():46-54. PubMed ID: 34102284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NADPH Oxidase 1 in Liver Macrophages Promotes Inflammation and Tumor Development in Mice.
    Liang S; Ma HY; Zhong Z; Dhar D; Liu X; Xu J; Koyama Y; Nishio T; Karin D; Karin G; Mccubbin R; Zhang C; Hu R; Yang G; Chen L; Ganguly S; Lan T; Karin M; Kisseleva T; Brenner DA
    Gastroenterology; 2019 Mar; 156(4):1156-1172.e6. PubMed ID: 30445007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heat shock protein family A member 8 serving as a co-activator of transcriptional factor ETV4 up-regulates PHLDA2 to promote the growth of liver cancer.
    Wang S; Wang YF; Yang G; Zhang HH; Yuan HF; Hou CY; Zhao LN; Suo YH; Sun J; Sun LL; Lv P; Sun Y; Zhang NN; Zhang XD; Lu W
    Acta Pharmacol Sin; 2023 Dec; 44(12):2525-2536. PubMed ID: 37474643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ETV4 potentiates nuclear YAP retention and activities to enhance the progression of hepatocellular carcinoma.
    Xu X; Wang B; Liu Y; Jing T; Xu G; Zhang L; Kun Jiao ; Chen Z; Xiang L; Xu C; Yang Z; Liu Y
    Cancer Lett; 2022 Jul; 537():215640. PubMed ID: 35296440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cathepsin C Interacts with TNF-α/p38 MAPK Signaling Pathway to Promote Proliferation and Metastasis in Hepatocellular Carcinoma.
    Zhang GP; Yue X; Li SQ
    Cancer Res Treat; 2020 Jan; 52(1):10-23. PubMed ID: 31048666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nimbolide inhibits tumor growth by restoring hepatic tight junction protein expression and reduced inflammation in an experimental hepatocarcinogenesis.
    Ram AK; Vairappan B; Srinivas BH
    World J Gastroenterol; 2020 Dec; 26(45):7131-7152. PubMed ID: 33362373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Administration of Steamed and Freeze-Dried Mature Silkworm Larval Powder Prevents Hepatic Fibrosis and Hepatocellular Carcinogenesis by Blocking TGF-β/STAT3 Signaling Cascades in Rats.
    Lee DY; Yun SM; Song MY; Ji SD; Son JG; Kim EH
    Cells; 2020 Feb; 9(3):. PubMed ID: 32121064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.